FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2804038919> ?p ?o ?g. }

• W2804038919 endingPage "9" @default.
• W2804038919 startingPage "1" @default.
• W2804038919 abstract "Aims . To evaluate the effectiveness and safety of peritoneal dialysis (PD) in treating refractory congestive heart failure (RCHF) with cardiorenal syndrome (CRS). Methods . A total of 36 patients with RCHF were divided into type 2 CRS group (group A) and non-type 2 CRS group (group B) according to the patients’ clinical presentations and the ratio of serum urea to creatinine and urinary analyses in this prospective study. All patients were followed up till death or discontinuation of PD. Data were collected for analysis, including patient survival time on PD, technique failure, changes of heart function, and complications associated with PD treatment and hospitalization. Results . There were 27 deaths and 9 patients quitting PD program after a follow-up for 73 months with an average PD time of<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M1><mml:mn fontstyle=italic>22.8</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle=italic>18.2</mml:mn></mml:math>months. A significant longer PD time was found in group B as compared with that in group A (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M2><mml:mn fontstyle=italic>29.0</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle=italic>19.4</mml:mn></mml:math>versus<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M3><mml:mn fontstyle=italic>13.1</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle=italic>10.6</mml:mn></mml:math>months,<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M4><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle=italic>0.003</mml:mn></mml:math>). Kaplan–Meier curves showed a higher survival probability in group B than that in group A (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M5><mml:mi>p</mml:mi><mml:mo><</mml:mo><mml:mn fontstyle=italic>0.001</mml:mn></mml:math>). Multivariate regression demonstrated that type 2 CRS was an independent risk factor for short survival time on PD. The benefit of PD on the improvement of survival and LVEF was limited to group B patients, but absent from group A patients. The impairment of exercise tolerance indicated by NYHA classification was markedly improved by PD for both groups. The technique survival was high, and the hospital readmission was evidently decreased for both group A and group B patients. Conclusions . Our data suggest that PD is a safe and feasible palliative treatment for RCHF with type 2 CRS, though the long-term survival could not be expected for patients with the type 2 CRS. Registration ID Number is ChiCTR1800015910 ." @default.
• W2804038919 created "2018-06-01" @default.
• W2804038919 creator A5001208053 @default.
• W2804038919 creator A5008857498 @default.
• W2804038919 creator A5015487970 @default.
• W2804038919 creator A5020836046 @default.
• W2804038919 creator A5024147822 @default.
• W2804038919 creator A5026797774 @default.
• W2804038919 creator A5035282947 @default.
• W2804038919 creator A5035801785 @default.
• W2804038919 creator A5041867945 @default.
• W2804038919 creator A5046643606 @default.
• W2804038919 date "2018-01-01" @default.
• W2804038919 modified "2023-09-23" @default.
• W2804038919 title "Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure due to Chronic Cardiorenal Syndrome" @default.
• W2804038919 cites W1603137434 @default.
• W2804038919 cites W1839535760 @default.
• W2804038919 cites W1970580387 @default.
• W2804038919 cites W1982074891 @default.
• W2804038919 cites W1990452261 @default.
• W2804038919 cites W1993823264 @default.
• W2804038919 cites W2000186905 @default.
• W2804038919 cites W2005517740 @default.
• W2804038919 cites W2019076516 @default.
• W2804038919 cites W2022419600 @default.
• W2804038919 cites W2031797721 @default.
• W2804038919 cites W2032409670 @default.
• W2804038919 cites W2040858725 @default.
• W2804038919 cites W2041993174 @default.
• W2804038919 cites W2049186845 @default.
• W2804038919 cites W2049382000 @default.
• W2804038919 cites W2051948351 @default.
• W2804038919 cites W2054559645 @default.
• W2804038919 cites W2057872170 @default.
• W2804038919 cites W2062233960 @default.
• W2804038919 cites W2064956900 @default.
• W2804038919 cites W2080244032 @default.
• W2804038919 cites W2104402487 @default.
• W2804038919 cites W2104547465 @default.
• W2804038919 cites W2105920292 @default.
• W2804038919 cites W2110717352 @default.
• W2804038919 cites W2115198105 @default.
• W2804038919 cites W2118180854 @default.
• W2804038919 cites W2133204125 @default.
• W2804038919 cites W2148910374 @default.
• W2804038919 cites W2182375635 @default.
• W2804038919 cites W2182840660 @default.
• W2804038919 cites W2324950282 @default.
• W2804038919 cites W2341460098 @default.
• W2804038919 cites W3023363600 @default.
• W2804038919 doi "https://doi.org/10.1155/2018/6529283" @default.
• W2804038919 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5985089" @default.
• W2804038919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29888270" @default.
• W2804038919 hasPublicationYear "2018" @default.
• W2804038919 type Work @default.
• W2804038919 sameAs 2804038919 @default.
• W2804038919 citedByCount "7" @default.
• W2804038919 countsByYear W28040389192020 @default.
• W2804038919 countsByYear W28040389192021 @default.
• W2804038919 countsByYear W28040389192022 @default.
• W2804038919 countsByYear W28040389192023 @default.
• W2804038919 crossrefType "journal-article" @default.
• W2804038919 hasAuthorship W2804038919A5001208053 @default.
• W2804038919 hasAuthorship W2804038919A5008857498 @default.
• W2804038919 hasAuthorship W2804038919A5015487970 @default.
• W2804038919 hasAuthorship W2804038919A5020836046 @default.
• W2804038919 hasAuthorship W2804038919A5024147822 @default.
• W2804038919 hasAuthorship W2804038919A5026797774 @default.
• W2804038919 hasAuthorship W2804038919A5035282947 @default.
• W2804038919 hasAuthorship W2804038919A5035801785 @default.
• W2804038919 hasAuthorship W2804038919A5041867945 @default.
• W2804038919 hasAuthorship W2804038919A5046643606 @default.
• W2804038919 hasBestOaLocation W28040389191 @default.
• W2804038919 hasConcept C11413529 @default.
• W2804038919 hasConcept C126322002 @default.
• W2804038919 hasConcept C159641895 @default.
• W2804038919 hasConcept C2778176769 @default.
• W2804038919 hasConcept C2778198053 @default.
• W2804038919 hasConcept C2778715236 @default.
• W2804038919 hasConcept C2779056158 @default.
• W2804038919 hasConcept C2779978075 @default.
• W2804038919 hasConcept C2780306776 @default.
• W2804038919 hasConcept C33923547 @default.
• W2804038919 hasConcept C71924100 @default.
• W2804038919 hasConceptScore W2804038919C11413529 @default.
• W2804038919 hasConceptScore W2804038919C126322002 @default.
• W2804038919 hasConceptScore W2804038919C159641895 @default.
• W2804038919 hasConceptScore W2804038919C2778176769 @default.
• W2804038919 hasConceptScore W2804038919C2778198053 @default.
• W2804038919 hasConceptScore W2804038919C2778715236 @default.
• W2804038919 hasConceptScore W2804038919C2779056158 @default.
• W2804038919 hasConceptScore W2804038919C2779978075 @default.
• W2804038919 hasConceptScore W2804038919C2780306776 @default.
• W2804038919 hasConceptScore W2804038919C33923547 @default.
• W2804038919 hasConceptScore W2804038919C71924100 @default.
• W2804038919 hasLocation W28040389191 @default.
• W2804038919 hasLocation W28040389192 @default.
• W2804038919 hasLocation W28040389193 @default.

• next